From drought to demand: Biotech IPOs roar back with Kailera and Alamar [Yahoo! Finance]
Alamar Biosciences, Inc. - Class A common stock (ALMR)
Company Research
Source: Yahoo! Finance
The Alamar Biosciences CEO's IPO was one of two back-to-back blockbuster biotech offerings this week, a clear signal that investors are willing to open their wallets for life sciences companies again—under the right conditions. On Thursday, Kailera Therapeutics, an obesity drug developer, raised $625 million in what is believed to be the largest biotech IPO in Nasdaq history. The IPO priced 39.1 million shares at $16 (the top of its range). The company had initially set out to raise just $500 million. One day post-IPO, Kailera was already up 63 percent. On Friday, Alamar Biosciences, a precision proteomics (the study of proteins rather than genes) firm, priced its own upsized offering at $17 per share (the top of its range) raising $191.3 million after demand exceeded available shares by 11 times, Luo told Fortune . Much like Kailera, Alamar shares soared , up 33% on the first day of trading. For Alamar in particular, the listing carries symbolic weight. The life sciences tools
Show less
Read more
Impact Snapshot
Event Time:
ALMR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALMR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALMR alerts
High impacting Alamar Biosciences, Inc. - Class A common stock news events
Weekly update
A roundup of the hottest topics
ALMR
News
- Precision Proteomics Leader Alamar Biosciences Lists on NASDAQPR Newswire
- Precision Proteomics Leader Alamar Biosciences Lists on NASDAQPR Newswire
- Precision Proteomics Leader Alamar Biosciences Lists on NASDAQPR Newswire
- Alamar Biosciences: Looking For An Early Detection [Seeking Alpha]Seeking Alpha
- From drought to demand: Biotech IPOs roar back with Kailera and Alamar [Yahoo! Finance Canada]Yahoo! Finance Canada
ALMR
Sec Filings
- 4/21/26 - Form EFFECT
- 4/20/26 - Form 4
- 4/20/26 - Form 4
- ALMR's page on the SEC website